• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺铁女性的口服铁补充剂:多少剂量?多久补充一次?

Oral iron supplementation in iron-deficient women: How much and how often?

机构信息

ETH Zurich, Laboratory of Human Nutrition, Institute of Food Nutrition and Health, Schmelzbergstrasse 7, CH-8092, Zurich, Switzerland.

ETH Zurich, Laboratory of Human Nutrition, Institute of Food Nutrition and Health, Schmelzbergstrasse 7, CH-8092, Zurich, Switzerland; Swiss Distance University of Applied Sciences, Nutrition Group, Health Department, CH-8105, Regensdorf, Switzerland.

出版信息

Mol Aspects Med. 2020 Oct;75:100865. doi: 10.1016/j.mam.2020.100865. Epub 2020 Jul 7.

DOI:10.1016/j.mam.2020.100865
PMID:32650997
Abstract

Iron deficiency and iron deficiency anemia (IDA) are major public health problems worldwide, especially in young women. Oral iron supplementation can be an effective strategy to treat and prevent IDA, but guidelines vary. Some experts recommend doses of 150-200 mg elemental iron per day, with the dose split through the day. However, recent studies suggest this may not be an optimal regimen. The fraction of iron absorbed from high doses of oral iron is low, and unabsorbed iron can cause gut irritation, inflammation and dysbiosis, and these reduce compliance. In recent studies using serum hepcidin profiles and stable iron isotopes to quantify iron absorption in young women, we have shown that: (a) oral iron doses ≥60 mg in iron-deficient women, and doses ≥100 mg in women with IDA, stimulate an acute increase in hepcidin that persists 24 h after the dose, but subsides by 48 h; (b) therefore, to maximize fractional iron absorption, oral doses ≥60 mg should be given on alternate days; (c) the circadian increase in plasma hepcidin is augmented by a morning iron dose; therefore, iron doses should not be given in the afternoon or evening after a morning dose. If rate of Hb response is important, a pooled analysis of our data done for this review indicates that total iron absorption is also higher if twice the target daily iron dose is given on alternate days. In summary, these studies suggest changing from daily to alternate-day schedules and from divided to morning single doses increases iron absorption and may reduce side effects. Thus, providing morning doses of 60-120 mg iron as a ferrous salt given with ascorbic acid on alternate days may be an optimal oral dosing regimen for women with iron-deficiency and mild IDA.

摘要

铁缺乏和缺铁性贫血(IDA)是全球主要的公共卫生问题,尤其是在年轻女性中。口服铁补充剂是治疗和预防 IDA 的有效策略,但指南有所不同。一些专家建议每天补充 150-200mg 元素铁,剂量分在一天中服用。然而,最近的研究表明,这可能不是最佳方案。口服铁高剂量时,铁的吸收率较低,未被吸收的铁会引起肠道刺激、炎症和菌群失调,从而降低患者的依从性。在最近使用血清铁调素谱和稳定铁同位素来量化年轻女性铁吸收的研究中,我们已经表明:(a)在铁缺乏的女性中,口服铁剂量≥60mg,在 IDA 女性中剂量≥100mg,会刺激铁调素急性增加,这种增加会持续到剂量后 24 小时,但在 48 小时后会缓解;(b)因此,为了最大限度地提高铁的吸收率,口服剂量≥60mg 应隔天服用;(c)铁调素的昼夜节律性增加会被早晨的铁剂量增强;因此,早晨服用铁剂后,下午或晚上不应再服用铁剂。如果 Hb 反应率很重要,对我们为此综述进行的数据分析表明,如果将每天的目标铁剂量加倍,隔天服用,总铁吸收率也会更高。总之,这些研究表明,从每日方案改为隔日方案,从分剂量改为早晨单次剂量,可以增加铁的吸收,减少副作用。因此,每天早上服用 60-120mg 亚铁盐,同时服用抗坏血酸,作为一种替代方案,可能是缺铁和轻度 IDA 女性的最佳口服补铁方案。

相似文献

1
Oral iron supplementation in iron-deficient women: How much and how often?缺铁女性的口服铁补充剂:多少剂量?多久补充一次?
Mol Aspects Med. 2020 Oct;75:100865. doi: 10.1016/j.mam.2020.100865. Epub 2020 Jul 7.
2
Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials.在缺铁女性中,连续每日与隔日服用口服铁补充剂,以及早晨单次给药与每日两次分剂量给药的铁吸收情况:两项开放标签随机对照试验。
Lancet Haematol. 2017 Nov;4(11):e524-e533. doi: 10.1016/S2352-3026(17)30182-5. Epub 2017 Oct 9.
3
Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women.在缺铁性贫血的女性中,隔日补充比连续日补充能更有效地吸收补充剂中的铁。
Haematologica. 2020 May;105(5):1232-1239. doi: 10.3324/haematol.2019.220830. Epub 2019 Aug 14.
4
The effect of iron dosing schedules on plasma hepcidin and iron absorption in Kenyan infants.肯尼亚婴儿铁剂给药方案对血浆铁调素和铁吸收的影响。
Am J Clin Nutr. 2020 Oct 1;112(4):1132-1141. doi: 10.1093/ajcn/nqaa174.
5
Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women.口服铁补充剂会增加铁调素,从而降低缺铁年轻女性每天或每天两次服用铁剂的铁吸收率。
Blood. 2015 Oct 22;126(17):1981-9. doi: 10.1182/blood-2015-05-642223. Epub 2015 Aug 19.
6
A Prospective, Randomized, Interventional Study of Oral Iron Supplementation Comparing Daily Dose with Alternate Day Regimen Using Hepcidin as a Biomarker in Iron Deficiency Anemia.一项前瞻性、随机、干预性研究:在缺铁性贫血中,以铁调素作为生物标志物,比较每日剂量与隔日疗法的口服铁补充剂。
J Assoc Physicians India. 2020 May;68(5):39-41.
7
Comparing therapeutic effects of alternate day versus daily oral iron in women with iron deficiency anemia: A retrospective cohort study.比较隔日与每日口服铁剂治疗缺铁性贫血女性患者的疗效:一项回顾性队列研究。
Medicine (Baltimore). 2023 Jul 28;102(30):e34421. doi: 10.1097/MD.0000000000034421.
8
Effect of dietary factors and time of day on iron absorption from oral iron supplements in iron deficient women.膳食因素和时间对缺铁女性口服铁补充剂中铁吸收的影响。
Am J Hematol. 2023 Sep;98(9):1356-1363. doi: 10.1002/ajh.26987. Epub 2023 Jun 26.
9
Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia.随机对照试验:每日 2 次与隔日口服铁剂治疗缺铁性贫血的疗效比较。
Ann Hematol. 2020 Jan;99(1):57-63. doi: 10.1007/s00277-019-03871-z. Epub 2019 Dec 6.
10
The opposing effects of acute inflammation and iron deficiency anemia on serum hepcidin and iron absorption in young women.急性炎症和缺铁性贫血对年轻女性血清铁调素和铁吸收的相反作用。
Haematologica. 2019 Jun;104(6):1143-1149. doi: 10.3324/haematol.2018.208645. Epub 2019 Jan 10.

引用本文的文献

1
Iron Deficiency and Iron Deficiency Anemia: A Comprehensive Overview of Established and Emerging Concepts.缺铁与缺铁性贫血:既定概念与新兴概念的全面概述
Pharmaceuticals (Basel). 2025 Jul 25;18(8):1104. doi: 10.3390/ph18081104.
2
Global burden of anemia attributable to non-communicable diseases: GBD 2021 analysis and projections.非传染性疾病所致贫血的全球负担:全球疾病负担研究2021分析与预测
Front Nutr. 2025 Aug 6;12:1557986. doi: 10.3389/fnut.2025.1557986. eCollection 2025.
3
Exploring tolerance and side effects of an innovative yeast-bound iron supplement: a feasibility trial.
探索一种新型酵母结合铁补充剂的耐受性和副作用:一项可行性试验。
Pilot Feasibility Stud. 2025 Aug 15;11(1):110. doi: 10.1186/s40814-025-01690-w.
4
Cobalamin and iron deficiency still presents a challenge in hereditary hemorrhagic telangiectasia.钴胺素和铁缺乏在遗传性出血性毛细血管扩张症中仍然是一个挑战。
Sci Rep. 2025 Aug 4;15(1):28463. doi: 10.1038/s41598-025-13911-6.
5
Management of paediatric ulcerative colitis, part 1: Ambulatory care-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation.小儿溃疡性结肠炎的管理,第1部分:门诊护理——欧洲儿科胃肠病学、肝病学和营养学会以及欧洲克罗恩病和结肠炎组织的循证共识指南更新版
J Pediatr Gastroenterol Nutr. 2025 Sep;81(3):765-815. doi: 10.1002/jpn3.70097. Epub 2025 Jul 18.
6
Bioconversion of FeO Nanoparticles by Probiotics.益生菌对FeO纳米颗粒的生物转化
Pharmaceuticals (Basel). 2025 Apr 8;18(4):542. doi: 10.3390/ph18040542.
7
Cost-Effectiveness of Ferritin Screening Thresholds for Iron Deficiency in Reproductive-Age Women.育龄妇女缺铁时铁蛋白筛查阈值的成本效益
Am J Hematol. 2025 Jul;100(7):1132-1140. doi: 10.1002/ajh.27686. Epub 2025 Apr 16.
8
Assessment of the intensive phase 'Shakti Divas' initiative to combatting anemia in Rajasthan, India.印度拉贾斯坦邦“力量日”强化阶段防治贫血倡议的评估。
PLoS One. 2025 Mar 13;20(3):e0319520. doi: 10.1371/journal.pone.0319520. eCollection 2025.
9
Iron optimisation in pregnancy: a Haematology in Obstetric and Women's Health Collaborative consensus statement.孕期铁优化:产科与女性健康血液学协作组共识声明
Intern Med J. 2025 Feb;55(2):300-307. doi: 10.1111/imj.16602. Epub 2025 Feb 5.
10
Comparative analysis of oral iron therapy regimens in premenopausal women with iron deficiency anemia.绝经前缺铁性贫血女性口服铁剂治疗方案的比较分析
Sci Rep. 2024 Dec 28;14(1):30671. doi: 10.1038/s41598-024-76667-5.